Table 1 Overall survival rates of the patients with intrahepatic cholangiocarcinoma according to the clinicopathologic variables

From: The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas

 

No.

1-year (%)

3-year (%)

5-year (%)

P-value

Gender

 Male

60

58.33

39.36

31.53

0.62

 Female

41

75.61

43.62

34.98

 

Age

 <65

53

66.04

40.82

31.02

0.92

 ⩾65

48

64.58

41.16

35.84

 

Satellite nodule(s)

 Present

15

33.33

13.33

13.33

0.0013*

 Absent

86

70.93

45.77

36.32

 

Size (cm)

 ⩽5

63

73.02

44.89

39.01

0.0524

 >5

38

52.63

31.58

21.65

 

Differentiation

 Well/moderate

64

67.19

45.12

35.71

0.0257*

 Poor

28

53.57

21.43

16.07

 

Vascular invasion

 Present

42

47.62

25.54

19.15

0.0029*

 Absent

59

77.97

51.83

40.9

 

Perineural invasion

 Present

31

51.61

21.77

12.1

0.0034*

 Absent

70

71.43

49.32

41.75

 

LN metastasis

 Present

27

33.33

18.52

12.35

<0.0001*

 Absent

74

77.03

49.23

40.04

 

Resection margin

 Involved

7

85.71

28.57

28.57

0.76

 Clear

94

63.83

42

33.33

 

pT classification

 1

52

76.92

54.95

42.28

0.0181*

 2

32

62.5

26.52

19.89

 

 3

15

33.33

26.67

26.67

 

 4

2

50

0

0

 
  1. *Significant at the level of P<0.05.
  2. Survival rates were estimated using Kaplan–Meier method and the P-value was drawn by log-rank test.
Back to article page